Putting PPI adverse effects in perspective
Proton pump inhibitors (PPIs) perennially rank among the top three classes of oral medications by sales in the United States. In the U.S., 10 to 15 percent of adults have used a PPI within the last year and eight to 10 percent have used a PPI within the last 30 days. Yet simultaneously there seems to be tremendous concern regarding […]
